Related references
Note: Only part of the references are listed.MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins
Hong Chen et al.
CANCER LETTERS (2012)
Smad4-Mediated Signaling Inhibits Intestinal Neoplasia by Inhibiting Expression of β-Catenin
Tanner J. Freeman et al.
GASTROENTEROLOGY (2012)
Smad4-mediated TGF-β signaling in tumorigenesis
Guan Yang et al.
International Journal of Biological Sciences (2012)
Keratinization-associated miR-7 and miR-21 Regulate Tumor Suppressor Reversion-inducing Cysteine-rich Protein with Kazal Motifs (RECK) in Oral Cancer
Hyun Min Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma
Zhaojian Liu et al.
JOURNAL OF PATHOLOGY (2012)
Tumor Suppressor MicroRNA-493 Decreases Cell Motility and Migration Ability in Human Bladder Cancer Cells by Downregulating RhoC and FZD4
Koji Ueno et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Involvement of the SKP2-p27KIP1 pathway in suppression of cancer cell proliferation by RECK
Y. Yoshida et al.
ONCOGENE (2012)
Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer
Sabrina Thalita Reis et al.
BMC UROLOGY (2012)
MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells
Syunsuke Noguchi et al.
CANCER LETTERS (2011)
Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer
Maartje G. Noordhuis et al.
CLINICAL CANCER RESEARCH (2011)
Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines
Arnulf Stenzl et al.
EUROPEAN UROLOGY (2011)
microRNA-203 suppresses bladder cancer development by repressing bcl-w expression
Juanjie Bo et al.
FEBS JOURNAL (2011)
MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3
Li Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
miR-183-96-182 Cluster Is Overexpressed in Prostate Tissue and Regulates Zinc Homeostasis in Prostate Cells
Brittany L. Mihelich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
beta-Catenin activation synergizes with PTEN loss to cause bladder cancer formation
I. Ahmad et al.
ONCOGENE (2011)
MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing
Yonghua Han et al.
PLOS ONE (2011)
Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis
I. Ahmad et al.
CELL DEATH & DISEASE (2011)
miR-182 as a Prognostic Marker for Glioma Progression and Patient Survival
Lili Jiang et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
T. Chiyomaru et al.
BRITISH JOURNAL OF CANCER (2010)
Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene FOXO1 in Endometrial Cancer
Stephen S. Myatt et al.
CANCER RESEARCH (2010)
Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC)
Courtney Pollard et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2010)
MicroRNA control of signal transduction
Masafumi Inui et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Theranostic and prognostic biomarkers: genomic applications in urological malignancies
George J. Netto et al.
PATHOLOGY (2010)
Smad4 restoration leads to a suppression of Wnt/β-catenin signaling activity and migration capacity in human colon carcinoma cells
Xiaoxiao Tian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
Lars Dyrskjot et al.
CANCER RESEARCH (2009)
Signaling cross-talk between TGF-beta/BMP and other pathways
Xing Guo et al.
CELL RESEARCH (2009)
miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
Liana Adam et al.
CLINICAL CANCER RESEARCH (2009)
Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
Irene K. Guttilla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
MicroRNAs as potential cancer therapeutics
P Trang et al.
ONCOGENE (2009)
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
Miguel F. Segura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Functional blockade of Smad4 leads to a decrease in β-catenin levels and signaling activity in human pancreatic carcinoma cells
Diana Romero et al.
CARCINOGENESIS (2008)
Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways
Herve Wallerand et al.
CURRENT OPINION IN UROLOGY (2008)
Bladder cancer angiogenesis and metastasis-translation from murine model to clinical trial
Peter C. Black et al.
CANCER AND METASTASIS REVIEWS (2007)
Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation
Hui-Chiu Chang et al.
CANCER RESEARCH (2006)
WNT and β-catenin signalling:: Diseases and therapies
RT Moon et al.
NATURE REVIEWS GENETICS (2004)
Metastasis markers in bladder cancer: A review of the literature and clinical considerations
P Gontero et al.
EUROPEAN UROLOGY (2004)
RECK: A novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling
M Noda et al.
CANCER AND METASTASIS REVIEWS (2003)
Share Paper
